Andrew Saik Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Saik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Saik. Andrew Saik is CFO in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Financial Officer in Edge Therapeutics, Inc. ($EDGE) and Chief Financial Officer in Menlo Therapeutics Inc. ($MNLO).
Latest Insider Trading Transactions of Andrew Saik
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AUXL, EDGE, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Payment of Exercise | F | 6.84 | 762 | 5,212 | 113,451 | 114.2 K to 113.5 K (-0.67 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |
| May 08 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 1.95 | 250,000 | 487,500 | 250,000 | |
| May 08 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 250,000 | 0 | 300,000 | 50 K to 300 K (+500.00 %) |
| Mar 24 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 3.13 | 100,000 | 313,000 | 100,000 | |
| Mar 24 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jun 07 2019 | EDGE | PDS Biotechnology ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 6.39 | 62,715 | 400,749 | 62,715 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 82,999 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Buy | M | 0.00 | 82,999 | 0 | 82,999 | 0 to 83 K |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 82,999 | 0 | 82,999 | |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 82,999 | 0 | 82,999 | |
| Jun 20 2018 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 1.10 | 166,001 | 182,601 | 166,001 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 14.98 | 50,000 | 749,000 | 50,000 | |
| Nov 03 2017 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 10.73 | 200,000 | 2,146,000 | 200,000 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Option Exercise | J | 17.51 | 165,000 | 2,889,150 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Sell | J | 36.53 | 10,000 | 365,300 | 0 | 10 K to 0 (-100.00 %) |
| Aug 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Option Exercise | A | 17.51 | 165,000 | 2,889,150 | 165,000 | |
| Aug 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Saik Andrew | CFO | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1